| Issue Date | Title | Author(s) |
| Nov-2012 | Combined application of targeted therapy and immunotherapy in chronic myeloid leukaemia | Foroni, Letizia; Rezvani, Katy; de Lavallade, Hugues Francois |
| Feb-2016 | Genome-wide DNA methylation in chronic myeloid leukaemia | Apperley, Jane; Foroni, Letizia; Bazeos, Alexandra; |
| May-2013 | Investigation of molecular heterogeneity and new prognostic biomarkers in chronic myeloid leukaemia | Reid, Alistair; Foroni, Letizia; Daghistani, Mustafa; |
| Aug-2018 | Molecular pathology of Diamond Blackfan anaemia | Foroni, Letizia; Karadimitris, Anastasios; Al-Oqaily, Qais; |
| Apr-2016 | Personalised genetic management of CML | Reid, Alistair; Apperley, Jane; Foroni, Letizia; Alikian, Mary; , et al |
| 2012 | Prognostic factors in Chronic Myeloid Leukaemia therapy | Marin Costa, David; Foroni, Letizia; Ibrahim, Amr Reda Ahmed El Bahy |
| Jan-2013 | Role of human interleukin-17 producing T cells (Th17) and regulatory (Foxp3+) T cells in graft versus host disease (GvHD) | Rezvani, Katy; Foroni, Letizia; Alsuliman, Abdullah Saleh A |
| Aug-2012 | The role of the killer immunoglobulin-like receptor in haematological malignancies and stem cell transplantation | Rezvani, Katayoun; Foroni, Letizia; Gabriel, Ian |
| 1990 | Structural studies on the human Vk locus and on immunoglobulin gene rearrangements in leukaemic cells | Foroni, Letizia |
| May-2013 | Technical and clinical evaluation of the BCR-ABL1 tyrosine kinase domain mutation analysis in patients with chronic myeloid leukaemia | Foroni, Letizia; Apperley, Jane; Rossi, Natali'; |